5CL-ADB-A is a synthetic cannabinoid that is structurally related to the class of cannabinoids known as indazole-3-carboxamides. It was first identified in products obtained from online vendors in 2018.
5CL-ADB-A has been reported to have potent effects on the endocannabinoid system, acting as a full agonist at both the CB1 and CB2 receptors. This means that it has the potential to produce intense and long-lasting effects, similar to those of other synthetic cannabinoids.
The exact pharmacological and toxicological properties of 5CL-ADB-A are not fully understood, as research on the compound is limited. However, it is known to be highly potent, with users reporting strong psychoactive effects at low doses.
Due to its potency and potential for abuse, 5CL-ADB-A is considered to be a dangerous substance and has been classified as a controlled substance in some jurisdictions. Its use is associated with a range of adverse effects, including anxiety, paranoia, hallucinations, and cardiovascular problems.
Overall, 5CL-ADB-A is a synthetic cannabinoid that poses significant health risks and should be avoided. Users are advised to exercise caution and seek medical help if they experience any adverse effects after using the substance.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page